Combined effects of botulinum toxin and splinting therapy on upper limb spasticity

Combined effects of botulinum toxin and splinting therapy on upper limb spasticity - Combined effects of botulinum toxin and splinting therapy on upper limb spasticity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032170

Enrollment

Registered

2018-05-01

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with upper limb spasticity

Interventions

botulinum toxin combined with splinting therapy(sleep time, three month period) botulinum therapy alone(three month period)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)patients with post-stroke hemiparesis, upper limb spasticity,6 month or more after stroke onset. 2)patients with Brunnstrome recovery stage 2 or 3

Exclusion criteria

Exclusion criteria: 1)patients with no adaptation to botulinum toxin A 2)Patients with disturbance of consciousness or higher brain dysfunction who were considered to be inappropriate to participate in the study 3)Patients with severe limitation of range of motion because of joint contracture

Design outcomes

Primary

Measure	Time frame
passive range of motion	—

Secondary

Measure	Time frame
Modified Ashworth Scale Brunnstrom recorvery stage Disability assessment scale attachment time of splint status of implementation of self training	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactTomoya Kitade

Hamamatsu City Rehabilitation Hospital Rehabilitaition

kitade-to@sis.seirei.or.jp053-471-8331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026